Literature DB >> 20434551

Report of an NIAID workshop on dengue animal models.

M Cristina Cassetti1, Anna Durbin, Eva Harris, Rebeca Rico-Hesse, John Roehrig, Alan Rothman, Stephen Whitehead, Ramya Natarajan, Catherine Laughlin.   

Abstract

Dengue is a mosquito-borne viral disease of humans that has re-emerged in many parts of the world and has become an important international public health threat. Dengue incidence and geographical spread has dramatically increased in the last few decades and is now affecting most tropical and sub-tropical regions of the world. Despite extensive research efforts for several decades, no vaccines or therapeutics are currently available to prevent and treat dengue infections. One of the main obstacles to the development of countermeasures has been the lack of good animal models that recapitulate dengue pathogenesis in humans and reliably predict the safety and efficacy of countermeasures against dengue. In September 2008, the National Institute of Allergy and Infectious Diseases (NIAID) held a workshop to consider the current state-of-the-art developments in animal models for dengue and discuss strategies to accelerate progress in this field. This report summarizes the main discussions and recommendations that resulted from the meeting. (c) 2010. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20434551      PMCID: PMC2919823          DOI: 10.1016/j.vaccine.2010.04.045

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  39 in total

1.  Recombinant chimeric virus with wild-type dengue 4 virus premembrane and envelope and virulent yellow fever virus Asibi backbone sequences is dramatically attenuated in nonhuman primates.

Authors:  Charles E McGee; Mark G Lewis; Marisa St Claire; Wendeline Wagner; Jean Lang; Bruno Guy; Konstantin Tsetsarkin; Stephen Higgs; Thierry Decelle
Journal:  J Infect Dis       Date:  2008-03-01       Impact factor: 5.226

2.  A dengue fever viremia model in mice shows reduction in viral replication and suppression of the inflammatory response after treatment with antiviral drugs.

Authors:  Wouter Schul; Wei Liu; Hao-Ying Xu; Marie Flamand; Subhash G Vasudevan
Journal:  J Infect Dis       Date:  2007-01-23       Impact factor: 5.226

3.  Phase I clinical evaluation of rDEN4Delta30-200,201: a live attenuated dengue 4 vaccine candidate designed for decreased hepatotoxicity.

Authors:  Julie H McArthur; Anna P Durbin; Jennifer A Marron; Kimberli A Wanionek; Bhavin Thumar; Dennis J Pierro; Alexander C Schmidt; Joseph E Blaney; Brian R Murphy; Stephen S Whitehead
Journal:  Am J Trop Med Hyg       Date:  2008-11       Impact factor: 2.345

4.  Humanized mice show clinical signs of dengue fever according to infecting virus genotype.

Authors:  Javier Mota; Rebeca Rico-Hesse
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

5.  Epitope determinants of a chimpanzee dengue virus type 4 (DENV-4)-neutralizing antibody and protection against DENV-4 challenge in mice and rhesus monkeys by passively transferred humanized antibody.

Authors:  Ching-Juh Lai; Ana P Goncalvez; Ruhe Men; Claire Wernly; Olivia Donau; Ronald E Engle; Robert H Purcell
Journal:  J Virol       Date:  2007-09-19       Impact factor: 5.103

6.  Dengue virus infection and immune response in humanized RAG2(-/-)gamma(c)(-/-) (RAG-hu) mice.

Authors:  Jes G Kuruvilla; Ryan M Troyer; Shamala Devi; Ramesh Akkina
Journal:  Virology       Date:  2007-08-16       Impact factor: 3.616

7.  Cross-reactive memory CD4+ T cells alter the CD8+ T-cell response to heterologous secondary dengue virus infections in mice in a sequence-specific manner.

Authors:  Coreen M Beaumier; Alan L Rothman
Journal:  Viral Immunol       Date:  2009-06       Impact factor: 2.257

8.  A protective role for dengue virus-specific CD8+ T cells.

Authors:  Lauren E Yauch; Raphaël M Zellweger; Maya F Kotturi; Afrina Qutubuddin; John Sidney; Bjoern Peters; Tyler R Prestwood; Alessandro Sette; Sujan Shresta
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

9.  Both virus and tumor necrosis factor alpha are critical for endothelium damage in a mouse model of dengue virus-induced hemorrhage.

Authors:  Hsuen-Chin Chen; Florence M Hofman; John T Kung; Yang-Ding Lin; Betty A Wu-Hsieh
Journal:  J Virol       Date:  2007-03-14       Impact factor: 5.103

Review 10.  Understanding the contribution of cellular immunity to dengue disease pathogenesis.

Authors:  Anuja Mathew; Alan L Rothman
Journal:  Immunol Rev       Date:  2008-10       Impact factor: 12.988

View more
  36 in total

1.  The necessity and quandaries of dengue vaccine development.

Authors:  Stephen J Thomas
Journal:  J Infect Dis       Date:  2011-02-01       Impact factor: 5.226

Review 2.  Barriers to preclinical investigations of anti-dengue immunity and dengue pathogenesis.

Authors:  Ashley L St John; Soman N Abraham; Duane J Gubler
Journal:  Nat Rev Microbiol       Date:  2013-05-08       Impact factor: 60.633

3.  The flavivirus dengue induces hypertrophy of white matter astrocytes.

Authors:  Kim M Lee; Kevin B Chiu; Hope A Sansing; Peter J Didier; Andrew A Lackner; Andrew G MacLean
Journal:  J Neurovirol       Date:  2016-06-06       Impact factor: 2.643

4.  Dengue human infection model: introduction.

Authors:  M Cristina Cassetti; Stephen J Thomas
Journal:  J Infect Dis       Date:  2014-06-15       Impact factor: 5.226

Review 5.  Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health.

Authors:  Nikos Vasilakis; Jane Cardosa; Kathryn A Hanley; Edward C Holmes; Scott C Weaver
Journal:  Nat Rev Microbiol       Date:  2011-06-13       Impact factor: 60.633

6.  Competitive inhibitor of cellular α-glucosidases protects mice from lethal dengue virus infection.

Authors:  Jinhong Chang; Wouter Schul; Andy Yip; Xiaodong Xu; Ju-Tao Guo; Timothy M Block
Journal:  Antiviral Res       Date:  2011-08-11       Impact factor: 5.970

7.  Infection dynamics of sylvatic dengue virus in a natural primate host, the African Green Monkey.

Authors:  Kathryn A Hanley; Mathilde Guerbois; Tiffany F Kautz; Meredith Brown; Stephen S Whitehead; Scott C Weaver; Nikos Vasilakis; Preston A Marx
Journal:  Am J Trop Med Hyg       Date:  2014-08-04       Impact factor: 2.345

Review 8.  Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virus.

Authors:  Kathryn A Hanley; Thomas P Monath; Scott C Weaver; Shannan L Rossi; Rebecca L Richman; Nikos Vasilakis
Journal:  Infect Genet Evol       Date:  2013-03-20       Impact factor: 3.342

9.  Rise and fall of vector infectivity during sequential strain displacements by mosquito-borne dengue virus.

Authors:  C C Andrade; K I Young; W L Johnson; M E Villa; C A Buraczyk; W B Messer; K A Hanley
Journal:  J Evol Biol       Date:  2016-08-08       Impact factor: 2.411

10.  The role of the mosquito in a dengue human infection model.

Authors:  Christopher N Mores; Rebecca C Christofferson; Silas A Davidson
Journal:  J Infect Dis       Date:  2014-06-15       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.